U.S. Biotech Stock News

On August 13, 2025, ARS Pharmaceuticals reported second quarter and six-month results, with quarterly revenue increasing to US$15.72 million from US$0.5 million a year ago and net loss widening to US$44.88 million from US$12.52 million over the same period. This combination of sharply higher revenue and a significantly larger net loss reflects both increased product uptake and sustained investment needs during commercial expansion. We'll explore how this surge in revenue alongside a growing...

If you are trying to decide what to do with PepsiCo stock right now, you are not alone. Whether you are weighing your next move or just checking in on a long-held position, it is a great time to take stock of what is driving PepsiCo’s share price. Over the last three months, the stock has crept up over 15%, showing a clear bounce from earlier in the year. On a five-year timeline, returns are still strong at 26%, despite a dip in the past twelve months. What is behind these moves? Like many...

Danaher (NYSE:DHR) has been on the radar for many investors lately, thanks to a sharp shift in the company’s share price in the past month. The life sciences and diagnostics giant has climbed 12% since early May, even as the broader market has moved sideways. This movement could catch investors’ attention and prompt questions about what, if anything, has changed for the business beyond the numbers on the screen. Looking at the past year, Danaher’s stock has been under pressure, dropping 22%...

Earlier this month, Open Text Corporation announced a major executive transition, appointing James McGourlay as Interim CEO and introducing organizational changes including a new Executive Committee after recent fourth-quarter earnings results showed revenue of US$1.31 billion and net income of US$28.83 million. Alongside the leadership change, the company raised its quarterly dividend by 5% and unveiled a substantial share repurchase program, reflecting a focus on returning value to...

CorMedix Inc. recently reported its second quarter 2025 results, highlighting a surge in sales to US$39.74 million and a swing to profitability with net income of US$19.83 million, compared to a net loss a year earlier. The company also issued full-year 2025 earnings guidance, projecting pro forma revenue between US$305 million and US$335 million, underlining significant progress following its acquisition of Melinta Therapeutics. We'll examine how CorMedix's shift to profitability and robust...

NasdaqGS:ALXO 1 Year Share Price vs Fair Value Explore ALX Oncology Holdings's Fair Values from the Community and...

If you have been staring at Accenture’s stock price, wondering if now is the right time to make a move, you are definitely not alone. Plenty of investors are reassessing their positions after a bumpy ride over the last year. Let’s be honest: seeing a share that’s been down nearly 22% over the past twelve months can make anyone second-guess their confidence. But if you take a step back, things get more interesting. Despite the recent turbulence, Accenture's five-year return is up over 14%, and...

If you’ve been watching Dow (DOW) lately, you might be scratching your head at its latest swing. The company’s shares have caught some fresh attention, with a sharp drop over the past month that stands out even among cyclical names. There is no big event or dramatic headline in play; rather, a steady move is making investors wonder if the price shift signals something deeper about the company’s prospects or if it is simply the market shifting gears. Across the year, Dow’s share price has...

Are you wondering whether now is the right moment to make a move on Agilent Technologies stock? You are not alone. With all the ups, downs, and headline noise in the market, deciding what to do next can feel trickier than ever. That's where a clear look at valuation—and what it means for you—comes into focus. Agilent’s stock has seen some turbulence lately. Over the past day, shares dipped slightly by about 0.8%, and the past week saw a roughly 1% drop. However, with a broader perspective,...

ON Semiconductor (ON) Stock Movement Raises Investor Questions ON Semiconductor (ON) has captured attention after a sharp drop of nearly 18% over the last month, prompting many investors to wonder if the recent price slide is sending a signal about the company's future. There has not been a single headline-grabbing event to trigger the move. In markets, silence can sometimes be just as telling as news. Whether this situation presents an opportunity or a warning sign is a key consideration...

If you have been eyeing DICK'S Sporting Goods and wondering if it deserves a spot in your portfolio, you are definitely not alone. The stock has given investors plenty to talk about lately, with some interesting twists on both the upside and downside. While the share price dipped slightly over the last week, it is up about 3% in the past month and has surged nearly 29% over the past three months. Even more impressive, if you look at a longer snapshot, DICK'S has returned over 120% in the past...

BioCryst Pharmaceuticals recently filed a US$90.2 million shelf registration to offer up to 11,000,000 shares and announced the departure of Dr. Helen Thackray, its chief research and development officer, who will transition to an advisory role through year-end. These developments reflect a simultaneous leadership transition and capital-raising initiative that could influence both operational direction and the company’s financial flexibility. We’ll examine how the shelf registration filing...

Some Mueller Water Products, Inc. ( NYSE:MWA ) shareholders may be a little concerned to see that the Independent...

Devon Energy (DVN) has been on investors’ radar after its stock moved nearly 6% higher over the past month, a shift that is sure to spark some renewed interest in the energy sector. There hasn’t been a single headline-grabbing announcement this week, but the steady climb stands out, especially for those who have followed the ups and downs of oil and gas stocks. When a company quietly gains ground like this, it is natural for shareholders and would-be buyers to wonder if the market is...

If you’ve been watching Micron Technology (MU) lately, you’ve likely noticed the latest price swing grabbing headlines. The company’s share price dipped roughly 4% in the last trading day, and while there wasn’t a major event or game-changing announcement behind the move, it’s the kind of action that can spark debate. Is this dip a signal or just noise? For investors weighing their next step with Micron, these sudden fluctuations are sometimes more about shifts in sentiment than dramatic...

Woodward, Inc. recently announced significant leadership changes within its Aerospace segment, naming Shawn McLevige as President and appointing Terry Voskuil as Chief Technology Officer, both effective October 1, 2025. This leadership realignment signals a strong emphasis on technology development and operational excellence as Woodward advances its growth and innovation agenda. We'll explore how the appointment of a CTO for Aerospace could shape Woodward's investment narrative and future...

Thinking about what to do with your Atlassian stock? You are definitely not alone. After all, with software companies constantly making headlines and market sentiment swinging quickly, it is smart to pause and really look at where TEAM stands right now. In the last month, the stock price has been on a bit of a rollercoaster, down about 14%. But if you zoom out, things start to look a little brighter: over the past year, Atlassian’s total return is up more than 5%, even after a bumpy run...

Certainly! Here is the revised article with em dashes removed and the formatting improved: If you’re holding shares of Two Harbors Investment (TWO) or considering adding it to your watchlist, the latest dividend news probably raised your eyebrows. The company’s Board of Directors just announced a reduced third quarter dividend for common shareholders, a move that often stirs debate about management’s outlook. While preferred dividends remain steady for now, this lower payout on common shares...

Teleflex Incorporated recently announced that its Barrigel rectal spacer is now available for purchase in Japan after securing regulatory approval, insurance coverage, and academic endorsement, with the first commercial cases commencing earlier this month. This marks the debut of the first and only sculptable non-animal stabilized hyaluronic acid rectal spacer in Japan, widening patient access to advanced prostate radiation therapy solutions in a major international healthcare market. We'll...

On August 8, 2025, Alpha Metallurgical Resources announced its second quarter and first half earnings, reporting revenue of US$550.27 million and a net loss of US$4.95 million for the quarter, both down substantially from the previous year, while also confirming that no shares were repurchased during this period. This shift from net profit to net loss amid declining sales marked a significant departure from the company’s recent financial trends and may raise investor concerns about near-term...

Earlier in August 2025, NuScale Power Corporation filed a US$500 million at-the-market equity offering and a US$177.1 million shelf registration, covering a range of securities including common and preferred stock, depositary shares, debt securities, warrants, and units. These capital-raising actions suggest efforts to reinforce financial flexibility but also raise the possibility of share dilution, which often prompts investor reassessment of long-term growth and funding needs. We'll look...

Welltower (WELL) has recently caught the attention of investors after its stock added nearly 1.5% in a single day, continuing a run of steady gains over the past month. While there was not a single headline-grabbing event driving the uptick, the consistent climb may prompt shareholders and potential buyers to consider whether the market is reassessing the company’s growth prospects. With strong financial results reported in the last quarter and growing investor appetite for real estate...

Thinking of buying, holding, or selling Altria Group stock? You are definitely not alone. With this long-standing tobacco giant trading at $67.58 recently, investors are watching its moves closely and crunching the numbers to decide their next step. Over the past month, Altria’s stock price has jumped almost 15%, while its year-to-date return is up an impressive 28.7%. Those strong returns, especially the 40% gain over the past year, have stirred up plenty of talk about the company’s growth...

Hertz Car Sales recently announced a nationwide expansion of its Rent2Buy® program and a collaboration with Amazon, allowing customers to browse, finance, and purchase pre-owned vehicles directly through Amazon Autos in over 100 cities. This move highlights a shift in the used car market as traditional rental firms embrace digital retail models, creating new competition for established online auto retailers. We'll explore how Hertz's partnership with Amazon to sell used vehicles online could...